Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Isolation and Molecular Profiling of Bone Marrow Micrometastases Identifies TWIST1 as a Marker of Early Tumor Relapse in Breast Cancer Patients
2007
ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
2001
Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer
2003
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
2008
Breast cancer stem cells: implications for therapy of breast cancer
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Comparison of HER2 status between primary tumor and disseminated tumor cells in␣primary breast cancer patients
2006
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Triple-Negative Breast Cancer
2010 Standout
Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy
2015
Dissecting the metastatic cascade
2004
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
2010
Cancer to bone: a fatal attraction
2011 Standout
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer
2003
Cancer Metastasis: Building a Framework
2006 Standout
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process
2005
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
2013
Epithelial-Mesenchymal Transitions
2004 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Metastasis prevention by targeting the dormant niche
2015
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Immunology and immunotherapy of colorectal cancer
2003
Significance, detection and markers of disseminated breast cancer cells
2006
Tumor metastasis: moving new biological insights into the clinic
2013
Environment-mediated drug resistance: a major contributor to minimal residual disease
2009
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
2006
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
2007 StandoutNature
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Molecular Determinants of Occult Metastatic Tumor Cells in Bone Marrow
2001
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
2002
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
2000
Emerging Biological Principles of Metastasis
2017 Standout
Enumeration of Circulating Tumor Cells in the Blood of Breast Cancer Patients After Filtration Enrichment: Correlation with Disease Stage
2004
EMT: 2016
2016 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases
2003
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
The basics of epithelial-mesenchymal transition
2009 Standout
Detection, clinical relevance and specific biological properties of disseminating tumour cells
2008
Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance
2004
Frequent EpCam protein expression in human carcinomas
2004
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Novel approaches to target the microenvironment of bone metastasis
2021
Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy
2005
Convergence of Wnt, ß-Catenin, and Cadherin Pathways
2004 StandoutScience
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Targeted therapies in control of EMT in carcinoma and fibrosis
2007
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
Simultaneous Immunohistochemical Detection of Tumor Cells in Lymph Nodes and Bone Marrow Aspirates in Breast Cancer and Its Correlation With Other Prognostic Factors
2001
Micrometastatic Disease and Metastatic Outgrowth: Clinical Issues and Experimental Approaches
2009
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Disseminated Tumor Cells of Breast Cancer Patients: A Strong Prognostic Factor for Distant and Local Relapse
2008
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.
2010
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Integrin α5β1 Promotes Survival of Growth-Arrested Breast Cancer Cells
2004
Metabolic reprogramming and cancer progression
2020 StandoutScience
Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients
2006
Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics.
2001
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Comparative Analysis of Micrometastasis to the Bone Marrow and Lymph Nodes of Node-Negative Breast Cancer Patients Receiving No Adjuvant Therapy
2001
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Isolated Tumor Cells in Bone Marrow Three Years after Diagnosis in Disease-Free Breast Cancer Patients Predict Unfavorable Clinical Outcome1
2004
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Circulating Tumor Cells and Bone Marrow Micrometastasis
2008
Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
2003
Works of F Willgeroth being referenced
Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.
1999
Lack of Effect of Adjuvant Chemotherapy on the Elimination of Single Dormant Tumor Cells in Bone Marrow of High-Risk Breast Cancer Patients
2000